Stocks & Investing
Stocks and Investing
Stocks and Investing
Thu, October 13, 2022
[ Thu, Oct 13th 2022
] - WOPRAI
[ Thu, Oct 13th 2022
] - WOPRAI
[ Thu, Oct 13th 2022
] - WOPRAI
[ Thu, Oct 13th 2022
] - WOPRAI
[ Thu, Oct 13th 2022
] - WOPRAI
[ Thu, Oct 13th 2022
] - WOPRAI
[ Thu, Oct 13th 2022
] - WOPRAI
[ Thu, Oct 13th 2022
] - WOPRAI
[ Thu, Oct 13th 2022
] - WOPRAI
[ Thu, Oct 13th 2022
] - WOPRAI
[ Thu, Oct 13th 2022
] - WOPRAI
[ Thu, Oct 13th 2022
] - WOPRAI
[ Thu, Oct 13th 2022
] - WOPRAI
[ Thu, Oct 13th 2022
] - WOPRAI
[ Thu, Oct 13th 2022
] - WOPRAI
[ Thu, Oct 13th 2022
] - WOPRAI
[ Thu, Oct 13th 2022
] - WOPRAI
[ Thu, Oct 13th 2022
] - WOPRAI
[ Thu, Oct 13th 2022
] - WOPRAI
[ Thu, Oct 13th 2022
] - WOPRAI
[ Thu, Oct 13th 2022
] - WOPRAI
[ Thu, Oct 13th 2022
] - WOPRAI
[ Thu, Oct 13th 2022
] - WOPRAI
[ Thu, Oct 13th 2022
] - WOPRAI
[ Thu, Oct 13th 2022
] - WOPRAI
[ Thu, Oct 13th 2022
] - WOPRAI
[ Thu, Oct 13th 2022
] - WOPRAI
[ Thu, Oct 13th 2022
] - WOPRAI
Matthew Harrison Maintained (BMRN) at Buy with Decreased Target to $111 on, Oct 13th, 2022
Matthew Harrison of Morgan Stanley, Maintained "BioMarin Pharmaceutical Inc." (BMRN) at Buy with Decreased Target from $117 to $111 on, Oct 13th, 2022.
Matthew has made no other calls on BMRN in the last 4 months.
There are 5 other peers that have a rating on BMRN. Out of the 5 peers that are also analyzing BMRN, 1 agrees with Matthew's Rating of Hold. Following is the relevant analyst calls for the last 4 months
- Andreas Argyrides of "Wedbush" Initiated at Hold and Held Target at $70 on, Monday, June 13th, 2022
These are the ratings of the 4 analyists that currently disagree with Matthew
- Christopher Raymond of "Piper Sandler" Maintained at Buy with Increased Target to $128 on, Tuesday, August 9th, 2022
- Gena Wang of "Barclays" Maintained at Buy with Increased Target to $125 on, Thursday, August 4th, 2022
- Joseph Schwartz of "SVB Leerink" Maintained at Buy with Increased Target to $122 on, Thursday, August 4th, 2022
- Olivia Brayer of "Cantor Fitzgerald" Initiated at Buy and Held Target at $110 on, Wednesday, July 13th, 2022
